Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive trial results

Completed

A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

NCT02130557

Conditions
Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +25 more
Locations
  • Pacific Cancer Medical Center, Inc. Anaheim, California, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • The Emory Clinic Atlanta, Georgia, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
View all 189 locations
View Trial Details

Related conditions